Skip to main content
Clinical Trials/ISRCTN31380482
ISRCTN31380482
Completed
Phase 2

Partnership in Prostate Cancer Care: the feasibility of an integrated system to improve patient outcomes and experience (the ICARE-P Study)

HS Birmingham South and Central CCG0 sites200 target enrollmentJanuary 9, 2017

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Specialty: Primary Care, Primary sub-specialty: Cancer
Sponsor
HS Birmingham South and Central CCG
Enrollment
200
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

Registry
who.int
Start Date
January 9, 2017
End Date
November 30, 2017
Last Updated
5 years ago
Study Type
Interventional
Sex
Male

Investigators

Sponsor
HS Birmingham South and Central CCG

Eligibility Criteria

Inclusion Criteria

  • 1\. Confirmed diagnosis of prostate cancer and are at any stage of the care pathway
  • 2\. Under any treatment regime
  • 3\. Diagnosed and/or treated at University Hospitals Birmingham (UHB) or are currently undergoing treatment at UHB
  • 4\. Able to read written and comprehend spoken English and complete outcome measures
  • 5\. Judged by their GP to have the capacity to participate
  • 6\. Aged 18 years or over
  • 7\. Able and willing to give informed consent

Exclusion Criteria

  • 1\. Aged under 18 years
  • 2\. Unable to give informed consent or complete outcome measures
  • 3\. Living in a care setting, suffering from severe mental health problems or unable to communicate in English

Outcomes

Primary Outcomes

Not specified

Similar Trials